Related Experiment Video
Updated: Apr 15, 2026

06:09
Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
9.7K
In vitro evidence for senescent multinucleated melanocytes as a source for tumor-initiating cells
C Leikam1, A L Hufnagel1, C Otto2
1Department of Physiological Chemistry I, University of Wurzburg, Biocenter, Am Hubland, Wurzburg, Germany.
Cell Death & Disease
|April 4, 2015
Summary
Melanoma oncogenes can cause cells to enter senescence, a cell cycle arrest. However, these senescent cells can evade this arrest, leading to tumor formation and aggressive cancer.
Area of Science:
- Cell Biology
- Cancer Research
- Oncology
Background:
- Oncogene-induced senescence (OIS) is a cell cycle arrest in melanocytes, typically presenting as a multinuclear state, acting as a cancer barrier.
- Recent findings challenge the notion that senescence is always irreversible.
- The potential for OIS cells to progress to cancer remains largely unknown.
Purpose of the Study:
- To investigate if cells undergoing OIS can evade senescence and contribute to cancer progression.
- To determine the mechanisms by which OIS cells might transform into tumor-initiating cells.
Main Methods:
- Prolonged expression of the melanoma oncogene N-RAS(61K) in pigment cells.
- Observation of cellular phenotypes and behavior following oncogene expression.
- Assessment of tumor initiation and growth in vivo.
Main Results:
- Prolonged N-RAS(61K) expression induced OIS in pigment cells.
- Senescent cells gave rise to mononucleated, stem-like cells that evaded OIS.
- These progeny cells were dedifferentiated, proliferative, anoikis-resistant, and formed aggressive, metastatic tumors.
- This study provides the first in vitro evidence of OIS evasion and subsequent transformation.
Conclusions:
- Senescence, induced by oncogenes in differentiated cells, can paradoxically serve as a trigger for tumor transformation.
- OIS evasion leads to the generation of highly aggressive, tumor-initiating cells.
- These findings highlight a novel mechanism of cancer development from senescent cells.
Related Concept Videos
Replicative Cell Senescence
4.6K
Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.6K
Cancer Stem Cells and Tumor Maintenance
6.4K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.4K
Skin Cancer
6.6K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.6K

